JANSSEN PHARMACEUTICALS, INC.;ACHILLION PHARMACEUTICALS, INC.
发明人:
Maria Gloria Beumont,Lieve Bijnens,Lawrence M. Blatt,Sushmita Mukherjee Chanda,John Fry,Eugene Jans,Thomas Naoki Kakuda,Sivi Mahadevan,Roel Mertens,Gaston Rafael Picchio,Alex Van Dijck,Peter Van Remoo
申请号：
US15656821
公开号：
US20180021360A1
申请日:
2017.07.21
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A method for the treatment of hepatitis C infection genotype 1, 2, 4, 5, or 6, but not genotype 3 is provided comprising administering an effective amount of a combination of Compound (I), Compound (II), and Compound (III), or independently optionally their pharmaceutically acceptable salt, solvate or hydrate, optionally in a solid fixed dose composition.
